Pilocarpine is a medication used primarily to treat glaucoma, dry mouth, and dry eyes. It also has a newer application for age-related near vision loss and plays a key role in diagnosing cystic fibrosis. Available as both eye drops and oral tablets, pilocarpine works by mimicking a natural chemical messenger in the nervous system, stimulating glands and muscles throughout the body.
How Pilocarpine Works
Pilocarpine belongs to a class of drugs called parasympathomimetics, meaning it mimics the “rest and digest” branch of the nervous system. It activates receptors called muscarinic receptors, which are found in smooth muscle, glands, and the eye. While it can bind to all five subtypes of these receptors, most of its therapeutic effects in humans come through one specific subtype (M3). When pilocarpine activates these receptors, it triggers glands to produce more saliva, tears, and sweat, and it causes certain muscles in the eye to contract.
Lowering Eye Pressure in Glaucoma
The longest-standing use for pilocarpine is treating glaucoma, a condition where elevated pressure inside the eye gradually damages the optic nerve. When applied as eye drops, pilocarpine causes the ciliary muscle inside the eye to contract. This tightens a structure called the scleral spur, which opens up the eye’s natural drainage channels and allows fluid to flow out more freely. The result is a 15% to 25% reduction in intraocular pressure.
Pilocarpine eye drops are used for both chronic open-angle glaucoma (the most common type) and acute angle-closure glaucoma, where eye pressure spikes suddenly and needs rapid treatment. For chronic glaucoma, it’s typically applied one to four times daily. In an acute crisis, drops are given much more frequently at first, then tapered as pressure comes down. Pilocarpine is often used alongside other glaucoma medications rather than as a standalone treatment.
Common side effects from the eye drops include temporary blurred vision, brow ache, headache, and eye irritation, all reported in 1% to 10% of users. Because pilocarpine constricts the pupil, it can reduce vision quality in dim lighting. With long-term use, lens changes are possible.
Treating Age-Related Near Vision Loss
In 2021, the FDA approved a low-concentration pilocarpine eye drop (sold as Vuity, at 1.25%) specifically for presbyopia, the gradual loss of close-up focusing ability that typically begins in your early to mid-40s. This was the first prescription eye drop approved for this condition.
The concept is straightforward: pilocarpine constricts the pupil to a smaller size, creating a “pinhole effect” that increases depth of focus and sharpens near vision without significantly blurring distance vision. The effect is temporary, lasting several hours per dose. It’s designed as a convenience option for people who want to reduce their reliance on reading glasses, not as a permanent fix.
Relieving Dry Mouth and Dry Eyes
Oral pilocarpine tablets are prescribed for two main causes of severe dry mouth: Sjögren’s syndrome, an autoimmune condition that attacks moisture-producing glands, and radiation therapy to the head and neck, which can permanently damage salivary glands. By stimulating muscarinic receptors on salivary glands, pilocarpine increases saliva production. Studies show a moderate increase in salivary flow, and the drug also improves dry eye symptoms compared to artificial tears alone.
That said, oral pilocarpine comes with a notable side effect burden. Because it stimulates glands throughout the body, not just in the mouth, sweating is the most common complaint. In short-term studies, about 22% of patients experienced excessive sweating. In longer-term use, that number climbed to 55%. Other common side effects include urinary frequency (11%), runny nose (10%), headache (8%), increased tearing (8%), and diarrhea (6%).
Tolerability is a real issue. In one comparative study, 47% of patients discontinued pilocarpine as a first-line therapy, with roughly equal numbers stopping because of side effects and because the drug wasn’t effective enough. An alternative medication, cevimeline, had significantly lower discontinuation rates (32% vs. 61%) and caused less severe sweating (11% vs. 25%).
Diagnosing Cystic Fibrosis
Pilocarpine plays a critical but very different role in the sweat test, which is the gold standard for diagnosing cystic fibrosis. In this procedure, a small amount of pilocarpine is delivered into the skin of the forearm using a mild electrical current (a process called iontophoresis). The pilocarpine stimulates local sweat glands to produce a controlled amount of sweat, typically 15 to 100 microliters. That sweat is then collected and analyzed for chloride concentration. People with cystic fibrosis have abnormally high chloride levels in their sweat because of a defective chloride channel in their cells. This test is routinely performed on newborns who screen positive for cystic fibrosis.
Who Should Not Use Pilocarpine
Oral pilocarpine is contraindicated in people with uncontrolled asthma, because stimulating muscarinic receptors can constrict the airways and trigger bronchospasm. It’s also contraindicated in acute iritis (inflammation of the iris) and in narrow-angle glaucoma when miosis could worsen the condition. Anyone with a known allergy to pilocarpine should avoid all forms of the drug.
Because pilocarpine stimulates the parasympathetic nervous system broadly, people with cardiovascular disease, chronic lung conditions, or kidney or gallbladder problems may need careful evaluation before starting oral tablets. The sweating, increased urination, and changes in heart rate that pilocarpine can cause are generally mild but can be problematic for people with certain underlying conditions.